Clinical Trials · NCT00442767

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

CompletedPhase 4Pramlintide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Montefiore Medical Center
Enrollment
8
Start date
Feb 2007
Locations
1 site, United States
Primary endpoint
Assess the Mean Area Under the Curve (AUC) for Blood Glucose Concentration in Subjects Treated With Pramlintide + Insulin, Compared to Insulin Alone
View Pramlintide compound reference